Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #29, April 2019
A New Jersey federal judge has denied a request by a Johnson & Johnson shareholder to issue an injunction forcing Johnson & Johnson’s shareholders to resolve their securities disputes via arbitration rather than class action litigation.
J&J Defendants Ask Bankruptcy Court to Assert Jurisdiction over Mesothelioma, Ovarian Cancer Talcum Powder Claims
Johnson & Johnson and Johnson & Johnson Consumer Inc. have filed a motion to fix venue for claims related to Imerys Talc America Inc.’s bankruptcy, arguing that underlying mesothelioma and ovarian cancer talcum powder claims affect the debtors’ estates.
Johnson & Johnson defendants have filed a brief defending a trial court order tossing a $417 million verdict in an ovarian cancer talcum powder case, maintaining that there is only a weak statistical association between talc and ovarian cancer.
The appeal relating to a trial court order that threw out a $417 million verdict in an ovarian cancer talcum powder verdict has been fully briefed, according the appellate court’s online docket.
J&J Defendants File Brief in Venue Dispute in Multi-Plaintiff Talc Case, Say Plaintiffs Have ‘Zero Connection’ to City of St. Louis
The Johnson & Johnson defendants involved in a multi-plaintiff talcum powder ovarian cancer case that was scheduled to be tried in January before the Missouri Supreme Court stopped it have filed a brief in support of their position that the claims should be severed and transferred, arguing that that joinder of plaintiffs who have “zero connection to the City of St. Louis with those of a single plaintiff whose claims are properly venued there is contrary to Missouri law.”
Missouri Appellate Court Permits Appeal of $70 Million Talc Verdict to Proceed Despite Imerys Talc’s Bankruptcy Proceedings
A Missouri appellate court has ordered the appeal of a $70 million talcum powder ovarian cancer verdict to proceed despite Imerys Talc America’s recent bankruptcy filing, noting that the Johnson & Johnson defendants requested that the entire appeal not be stayed.
Issue #28, March 2019
A Georgia state court slated to oversee the state’s first talcum powder ovarian cancer trial has rejected defense efforts to preclude testimony of three plaintiff expert witnesses, saying the challenges go to the credibility of the testimony, not the admissibility.
California jurors have awarded $29,491,000 at the conclusion of an asbestos cosmetic talcum powder case against Johnson & Johnson, accepting the plaintiff’s claims that the company’s talc products caused her to develop mesothelioma, HarrisMartin Publishing is reporting.
A Pennsylvania state court has stayed a jurisdiction-related appeal filed by Imerys Talc America Inc. in light of the company’s bankruptcy filing, saying that the proceedings would be continued until the court overseeing the bankruptcy action lifted the automatic stay.
U.S. House Subcommittee Schedules Public Hearing on Health Risks of Carcinogens in Consumer Products
The U.S. House of Representatives Subcommittee on Economic and Consumer Policy has scheduled a public hearing to examine the public health risks of carcinogens in consumer products, at which time it will look at the scientific evidence of health risks from long-term use of consumer products containing talc and federal regulatory framework over consumer products.